Article Versions Notes

Ariyoshi M, Yuge R, Kitadai Y, Shimizu D, Miyamoto R, Yamashita K, Hiyama Y, Takigawa H, Urabe Y, Oka S. WEE1 Inhibitor Adavosertib Exerts Antitumor Effects on Colorectal Cancer, Especially in Cases with p53 Mutations. Cancers. 2024; 16(18):3136. https://doi.org/10.3390/cancers16183136

Ariyoshi, Misa, Ryo Yuge, Yuki Kitadai, Daisuke Shimizu, Ryo Miyamoto, Ken Yamashita, Yuichi Hiyama, Hidehiko Takigawa, Yuji Urabe, and Shiro Oka. 2024. "WEE1 Inhibitor Adavosertib Exerts Antitumor Effects on Colorectal Cancer, Especially in Cases with p53 Mutations" Cancers 16, no. 18: 3136. https://doi.org/10.3390/cancers16183136

Ariyoshi, M., Yuge, R., Kitadai, Y., Shimizu, D., Miyamoto, R., Yamashita, K., Hiyama, Y., Takigawa, H., Urabe, Y., & Oka, S. (2024). WEE1 Inhibitor Adavosertib Exerts Antitumor Effects on Colorectal Cancer, Especially in Cases with p53 Mutations. Cancers, 16(18), 3136. https://doi.org/10.3390/cancers16183136